Insider · CIK 0002089301
Daniel Tardiff
Files at CAMP (Camp4 Therapeutics Corp). First filing Aug 19, 2026, latest Aug 19, 2026.
In brief
Daniel Tardiff files SEC Form 4 as officer at CAMP (Camp4 Therapeutics Corp). Since Aug 19, 2026, Daniel Tardiff has reported 0 open-market buys worth $0 and 1 open-market sell worth $8,273, the latest filed on Aug 19, 2026.
A track record needs three past buys with six months of prices behind them; Daniel Tardiff has 0, so none is measured yet.
The newest scored trade: sold $8,273 of CAMP on Aug 19, 2026, filed Aug 19, 2026, scored 43 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $8,273.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CAMP: Camp4 Therapeutics Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | Camp4 Therapeutics Corp | $8,273 1,738 shares | -100% | +230% from low-35% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 19, 2026 | CAMP CAMP4 Therapeutics Corporation | 1,738 0.00% of outstanding | $8,276 | Aug 19, 2026 | none |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | CAMP Camp4 Therapeutics Corp | SOpen-market sale Common Stock | -1,738 | $4.76 | $8,273 | 0 | Aug 19, 2026 |
| Apr 1, 2026 | CAMP Camp4 Therapeutics Corp | AGrant or award Stock Option (Right to Buy)derivative | +170,000 | $0.00 | $0 | 170,000 | Apr 3, 2026 |
| Dec 11, 2025 | CAMP Camp4 Therapeutics Corp | AGrant or award Stock Option (Right to Buy)derivative | +145,500 | $0.00 | $0 | 145,500 | Dec 22, 2025 |
Questions about Daniel Tardiff
Answered from the filings on this page, as of the latest one.
Is Daniel Tardiff buying or selling?
In the last 12 months Daniel Tardiff reported 0 open-market buys worth $0 and 1 open-market sell worth $8,273 on SEC Form 4; the latest was sold $8,273 of CAMP on Aug 19, 2026. Grants, option exercises and tax withholding are not counted.
How did Daniel Tardiff's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Daniel Tardiff has 0.
Where does Daniel Tardiff file Form 4?
Daniel Tardiff has filed Form 4 at CAMP (Camp4 Therapeutics Corp) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.